Huntington National Bank Amphastar Pharmaceuticals, Inc. Transaction History
Huntington National Bank
- $13.8 Billion
- Q4 2024
A detailed history of Huntington National Bank transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1,340 shares of AMPH stock, worth $41,915. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,340
Previous 979
36.87%
Holding current value
$41,915
Previous $47,000
4.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$186 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$84.9 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$57.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$49.9 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$43 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.53B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...